BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23828518)

  • 1. FOXO3 expression during colorectal cancer progression: biomarker potential reflects a tumour suppressor role.
    Bullock MD; Bruce A; Sreekumar R; Curtis N; Cheung T; Reading I; Primrose JN; Ottensmeier C; Packham GK; Thomas G; Mirnezami AH
    Br J Cancer; 2013 Jul; 109(2):387-94. PubMed ID: 23828518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased FOXO3 within advanced human colon cancer: implications of tumour suppressor function.
    Savkovic SD
    Br J Cancer; 2013 Jul; 109(2):297-8. PubMed ID: 23828519
    [No Abstract]   [Full Text] [Related]  

  • 3. LAMB3 promotes tumour progression through the AKT-FOXO3/4 axis and is transcriptionally regulated by the BRD2/acetylated ELK4 complex in colorectal cancer.
    Zhu Z; Song J; Guo Y; Huang Z; Chen X; Dang X; Huang Y; Wang Y; Ou W; Yang Y; Yu W; Liu CY; Cui L
    Oncogene; 2020 Jun; 39(24):4666-4680. PubMed ID: 32398865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of Ras-related protein 1A promotes an aggressive phenotype in colorectal cancer via PTEN/FOXO3/CCND1 pathway.
    Liu L; Yan X; Wu D; Yang Y; Li M; Su Y; Yang W; Shan Z; Gao Y; Jin Z
    J Exp Clin Cancer Res; 2018 Jul; 37(1):178. PubMed ID: 30064475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LKB1 downregulation may be independent of promoter methylation or FOXO3 expression in head and neck cancer.
    Ekizoglu S; Dalay N; Karaman E; Akdeniz D; Ozaydin A; Buyru N
    Transl Res; 2013 Aug; 162(2):122-9. PubMed ID: 23810581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations of Foxo3 and Foxo4 expressions with clinicopathological features and prognosis of bladder cancer.
    Wang Y; Kang XL; Zeng FC; Xu CJ; Zhou JQ; Luo DN
    Pathol Res Pract; 2017 Jul; 213(7):766-772. PubMed ID: 28554751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer.
    Weixler B; Cremonesi E; Sorge R; Muraro MG; Delko T; Nebiker CA; Däster S; Governa V; Amicarella F; Soysal SD; Kettelhack C; von Holzen UW; Eppenberger-Castori S; Spagnoli GC; Oertli D; Iezzi G; Terracciano L; Tornillo L; Sconocchia G; Droeser RA
    Oncotarget; 2015 Nov; 6(35):37588-99. PubMed ID: 26439988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor suppressor FOXO3 regulates ribonucleotide reductase subunit RRM2B and impacts on survival of cancer patients.
    Cho EC; Kuo ML; Liu X; Yang L; Hsieh YC; Wang J; Cheng Y; Yen Y
    Oncotarget; 2014 Jul; 5(13):4834-44. PubMed ID: 24947616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-153 supports colorectal cancer progression via pleiotropic effects that enhance invasion and chemotherapeutic resistance.
    Zhang L; Pickard K; Jenei V; Bullock MD; Bruce A; Mitter R; Kelly G; Paraskeva C; Strefford J; Primrose J; Thomas GJ; Packham G; Mirnezami AH
    Cancer Res; 2013 Nov; 73(21):6435-47. PubMed ID: 23950211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of ZNF148 in different developing stages of colorectal cancer and its prognostic value: a large Chinese study based on tissue microarray.
    Gao XH; Liu QZ; Chang W; Xu XD; Du Y; Han Y; Liu Y; Yu ZQ; Zuo ZG; Xing JJ; Cao G; Fu CG
    Cancer; 2013 Jun; 119(12):2212-22. PubMed ID: 23576061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOXD3, frequently methylated in colorectal cancer, acts as a tumor suppressor and induces tumor cell apoptosis under ER stress via p53.
    Xu M; Zhu J; Liu S; Wang C; Shi Q; Kuang Y; Fang X; Hu X
    Carcinogenesis; 2020 Sep; 41(9):1253-1262. PubMed ID: 31784734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forkhead Box Protein J1 (FOXJ1) is Overexpressed in Colorectal Cancer and Promotes Nuclear Translocation of β-Catenin in SW620 Cells.
    Liu K; Fan J; Wu J
    Med Sci Monit; 2017 Feb; 23():856-866. PubMed ID: 28209947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pin2/TRF1‑binding protein X1 inhibits colorectal cancer cell migration and invasion in vitro and metastasis in vivo via the nuclear factor‑κB signaling pathway.
    Jiang T; Li H; Jiang R; Li H; Hou P; Chen Y; Bai J; Song J
    Oncol Rep; 2018 Sep; 40(3):1533-1544. PubMed ID: 30015978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smad4 inactivation predicts for worse prognosis and response to fluorouracil-based treatment in colorectal cancer.
    Kozak MM; von Eyben R; Pai J; Vossler SR; Limaye M; Jayachandran P; Anderson EM; Shaffer JL; Longacre T; Pai RK; Koong AC; Chang DT
    J Clin Pathol; 2015 May; 68(5):341-5. PubMed ID: 25681512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p42.3: a promising biomarker for the progression and prognosis of human colorectal cancer.
    Yuan XS; Zhang Y; Guan XY; Dong B; Zhao M; Mao LL; Lu YY; Tian XY; Hao CY
    J Cancer Res Clin Oncol; 2013 Jul; 139(7):1211-20. PubMed ID: 23576022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarker alterations associated with distinct patterns of metastatic spread in colorectal cancer.
    Michl M; Taverna F; Kumbrink J; Schiergens TS; Heinemann V; Engel J; Kirchner T; Neumann J
    Virchows Arch; 2021 Apr; 478(4):695-705. PubMed ID: 33300106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lgr5 over-expression is positively related to the tumor progression and HER2 expression in stage pTNM IV colorectal cancer.
    Gao FJ; Chen JY; Wu HY; Shi J; Chen M; Fan XS; Huang Q
    Int J Clin Exp Pathol; 2014; 7(4):1572-9. PubMed ID: 24817953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoplasmic mislocalization of overexpressed FOXF1 is associated with the malignancy and metastasis of colorectal adenocarcinomas.
    Lo PK; Lee JS; Chen H; Reisman D; Berger FG; Sukumar S
    Exp Mol Pathol; 2013 Feb; 94(1):262-9. PubMed ID: 23103611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SPARC, FOXP3, CD8 and CD45 correlation with disease recurrence and long-term disease-free survival in colorectal cancer.
    Chew A; Salama P; Robbshaw A; Klopcic B; Zeps N; Platell C; Lawrance IC
    PLoS One; 2011; 6(7):e22047. PubMed ID: 21818290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CIAPIN1 in human colorectal cancer and its correlation with prognosis.
    Shi H; Zhou Y; Liu H; Chen C; Li S; Li N; Li X; Zhang X; Zhang H; Wang W; Zhao Q
    BMC Cancer; 2010 Sep; 10():477. PubMed ID: 20815902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.